Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back

The purpose of this study was to assess the impact of 3 months of aromatase inhibition together with progestin add-back on ovarian endometrioma size. This prospective cohort study was performed at University Medical Center (UC San Diego). Women trying to conceive were excluded. After informed consen...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Sanjay K., Foster, Warren G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515259/
https://www.ncbi.nlm.nih.gov/pubmed/26247030
http://dx.doi.org/10.1155/2015/878517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515259/
https://www.ncbi.nlm.nih.gov/pubmed/26247030
http://dx.doi.org/10.1155/2015/878517

Ejemplares similares